US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hemab Therapeutics Holdings, Inc.

34.00

+16.0088.89%

Post-market: 33.10-0.9000-2.65%19:59 EDT

Volume:4.11M

Turnover:128.93M

Market Cap:1.33B

PE:- -

High:36.61

Open:27.00

Low:27.00

Close:18.00

52wk High:36.61

52wk Low:27.00

Shares:39.21M

Float Shares:11.76M

Volume Ratio:- -

T/O Rate:34.96%

Dividend:- -

Dividend Rate:- -

ROE:-46.99%

ROA:-30.11%

PB:-7.55

PE(LYR):- -

Loading ...

Overview Company News Filings

Stock Track | Hemab Therapeutics Soars 50% on First Trading Day After IPO Pricing

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

BRIEF-Hemab Therapeutics Prices Upsized IPO Of 16,750,000 Shares At $18.00 Per Share

Hemab Therapeutics Holdings Inc - Prices IPO of 16,750,000 Shares at $18.00 per Share

THOMSON REUTERS

Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering

Hemab Therapeutics Holdings Inc - Sees IPO of 15,000,000 Common Shares - SEC Filing

THOMSON REUTERS

Biotech Firm Hemab Therapeutics Sets US IPO Target at Up to $212 Million

Hemab Therapeutics Launches Initial Public Offering

MT Newswires Live

Hemab Therapeutics Holdings Inc - Launches IPO of 11,764,706 Common Shares - SEC Filing

THOMSON REUTERS

Hemab Therapeutics Holdings Inc - Estimated IPO Price per Share Between $16.00 and $18.00 - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COAG/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COAG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","market":"US","secType":"STK","nameCN":"Hemab Therapeutics Holdings, Inc.","latestPrice":34,"timestamp":1777665600000,"preClose":18,"halted":0,"volume":4113516,"hourTrading":{"tag":"盘后","latestPrice":33.1,"preClose":34,"latestTime":"19:59 EDT","volume":24517,"amount":807452.3188,"timestamp":1777679985243,"change":-0.9,"changeRate":-0.026471,"amplitude":0.054412},"delay":0,"changeRate":0.8888888888888888,"floatShares":11764706,"shares":39207616,"eps":0,"marketStatus":"Market Closed","change":16,"latestTime":"05-01 16:00:00 EDT","open":27,"high":36.61,"low":27,"amount":128926048.828896,"amplitude":0.533889,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":7,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":18,"postHourTrading":{"tag":"盘后","latestPrice":33.1,"preClose":34,"latestTime":"19:59 EDT","volume":24517,"amount":807452.3188,"timestamp":1777679985243,"change":-0.9,"changeRate":-0.026471,"amplitude":0.054412},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","floatShares":11764706,"roa":"-30.11%","roe":"-46.99%","lyrEps":0,"shares":39207616,"dividePrice":0,"high":36.61,"amplitude":0.533889,"preClose":18,"low":27,"week52Low":27,"pbRate":"-7.55","week52High":36.61,"institutionHeld":0,"latestPrice":34,"eps":0,"divideRate":0,"volume":4113516,"delay":0,"ttmEps":0,"open":27,"prevYearClose":18,"prevWeekClose":18,"prevMonthClose":18,"prevQuarterClose":18,"fiveDayClose":18,"twentyDayClose":18,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COAG\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COAG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COAG\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COAG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COAG","date":"2026-05-01","current":-11.042152,"percent":1,"low":-11.042152,"twenty":-11.042152,"median":-11.042152,"eighty":-11.042152,"high":-11.042152,"avg":-11.042152,"sd":0,"marketCap":705737088},"quantilePoints":[{"date":"2026-05-01","current":-11.042152,"twenty":-11.042152,"median":-11.042152,"eighty":-11.042152,"marketCap":705737088}],"updateTime":1777803737289},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COAG\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1146146332","title":"Stock Track | Hemab Therapeutics Soars 50% on First Trading Day After IPO Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=1146146332","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146146332?lang=en_us&edition=fundamental","pubTime":"2026-05-02 01:07","pubTimestamp":1777655220,"startTime":"0","endTime":"0","summary":"Hemab Therapeutics Holdings Inc (COAG) saw its stock price soar 50.00% intraday on Friday, marking a dramatic debut on the public market.The surge follows the company's announcement that it priced...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632900306","title":"NASDAQ TRADE HALT  REASON NOT AVAILABLE AT 04:00 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2632900306","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632900306?lang=en_us&edition=fundamental","pubTime":"2026-05-01 16:00","pubTimestamp":1777622402,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  REASON NOT AVAILABLE AT 04:00 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nAQN2LXA3F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632747660","title":"BRIEF-Hemab Therapeutics Prices Upsized IPO Of 16,750,000 Shares At $18.00 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2632747660","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632747660?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:57","pubTimestamp":1777589850,"startTime":"0","endTime":"0","summary":"BRIEF-Hemab Therapeutics Prices Upsized IPO Of 16,750,000 Shares At $18.00 Per ShareApril 30 (Reuters) - Hemab Therapeutics Holdings Inc COAG.O:HEMAB THERAPEUTICS ANNOUNCES PRICING OF UPSIZED INITIAL ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUATBV24:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660781","title":"Hemab Therapeutics Holdings Inc - Prices IPO of 16,750,000 Shares at $18.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660781","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632660781?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:55","pubTimestamp":1777589719,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUATBV24:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632866698","title":"Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2632866698","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632866698?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:55","pubTimestamp":1777589700,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass. and COPENHAGEN, Denmark, April  30, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics Holdings, Inc. (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/30/3285621/0/en/Hemab-Therapeutics-Announces-Pricing-of-Upsized-Initial-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","LENZ","COAG","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631638131","title":"Hemab Therapeutics Holdings Inc - Sees IPO of 15,000,000 Common Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2631638131","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631638131?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:41","pubTimestamp":1777545670,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41D0T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131589465","title":"Biotech Firm Hemab Therapeutics Sets US IPO Target at Up to $212 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1131589465","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131589465?lang=en_us&edition=fundamental","pubTime":"2026-04-28 16:06","pubTimestamp":1777363570,"startTime":"0","endTime":"0","summary":"Clinical-stage biotechnology company Hemab Therapeutics Holdings Inc. (COAG.US) is aiming to raise up to $212 million through an initial public offering in the United States. According to a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COAG","LU1093756325.SGD","BK4588","BK4007","IE00BKVL7J92.USD","LU1093756168.USD","BK4585","NVO","NVOH","BK4581","NVOX","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4532","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630331871","title":"Hemab Therapeutics Launches Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2630331871","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630331871?lang=en_us&edition=fundamental","pubTime":"2026-04-27 22:53","pubTimestamp":1777301610,"startTime":"0","endTime":"0","summary":"Hemab Therapeutics said Monday it has launched an initial public offering of about 11.8 million shares of common stock, with pricing estimated to be between $16 and $18 per share.The company granted underwriters the option to purchase up to an additional 1.8 million shares at the initial public offering price.Net proceeds from the offering will be used to initiate a planned phase 3 clinical trial of sutacimig in Glanzmann thrombasthenia and report data from a phase 2 clinical trial of sutacimig in Factor VII deficiency, among others, the company said.Hemab Therapeutics said it has applied to list its common stock on Nasdaq under the symbol \"COAG.\"","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","LENZ","BK4139","IPOS","COAG","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630439354","title":"Hemab Therapeutics Holdings Inc - Launches IPO of 11,764,706 Common Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2630439354","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630439354?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:10","pubTimestamp":1777288235,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nFWN41A0PK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393528","title":"Hemab Therapeutics Holdings Inc - Estimated IPO Price per Share Between $16.00 and $18.00 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393528","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630393528?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:10","pubTimestamp":1777288235,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nFWN41A0PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}